Clinical Trial Update: Safety and Efficacy of Relamorelin Administered to Participants With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating safety and efficacy of relamorelin in participants with vomiting symptoms and moderate to severe diabetic gastroparesis has co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Gastroparesis

Drugs mentioned

• Relamorelin (relamorelin)

Snippet

Sponsor: Allergan | Conditions: Diabetes Mellitus, Diabetes Mellitus Complications | Phase 2 | Status: COMPLETED | Results posted: 2019-07-24